Snippet from the article:
Men diagnosed with prostate cancer will often put off chemotherapy, with their doctor’s approval. But new research suggests that men who get chemotherapy early on may actually live longer.
Typically, men with prostate cancer will start their treatment with simply active surveillance of their tumors, before starting hormone therapy. Men will undergo chemotherapy only when their tumors become resistant to hormone therapy. But a recent clinical trial found that men treated early with chemotherapy lived longer than men who underwent the standard treatment.
The clinical trial randomized 790 men with recently diagnosed prostate cancer into two groups. One followed the standard treatment guidelines, and the other received chemo right away alongside their hormone therapy. The men who underwent chemotherapy lived over a year longer than the men on the standard treatment regime.
The study was deemed among the most noteworthy of the thousands of studies presented at the annual meeting of the American Society of Clinical Oncology.